← All companies

CURX

Curanex Pharmaceuticals Inc

CURX Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.21

+0.02 +10.99%

Key statistics

from XBRL data in SEC filings

Market cap

$6.01M

Revenue (TTM)

—

Net income (TTM)

-$7.24M

EPS (TTM)

$-0.27

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$4.00M

Total assets

$8.41M

Gross margin

—

52-week range

$0.18 – $9.18

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure May 14, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Other events May 7, 2026 8-K Regulation FD disclosure Apr 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Entered a material agreement; Director or officer change Mar 6, 2026 8-K Director or officer change Jan 5, 2026 10-Q Quarter ended 2025-09-30 Nov 17, 2025 8-K Delisting notice or listing-rule failure Nov 6, 2025 8-K Unregistered sale of equity; Other events Sep 29, 2025 8-K Other events Sep 12, 2025 10-Q Quarter ended 2025-06-30 Sep 9, 2025 8-K Other events Aug 27, 2025 8-K Entered a material agreement; Other events Aug 26, 2025

Other filings

S-8 Jul 21, 2026 DEF 14C Jun 29, 2026 PRE 14C Jun 18, 2026 NT 10-Q Nov 17, 2025 3 Sep 2, 2025 3 Sep 2, 2025 3 Sep 2, 2025 3 Sep 2, 2025 3 Sep 2, 2025 3 Sep 2, 2025 3 Sep 2, 2025 3 Sep 2, 2025 3 Sep 2, 2025 424B4 Aug 26, 2025 424B4 Aug 26, 2025 CERT Aug 25, 2025 8-A12B Aug 25, 2025 EFFECT Aug 12, 2025 CORRESP Aug 8, 2025 CORRESP Aug 8, 2025 FWP Jul 22, 2025 S-1/A Jul 18, 2025 FWP Jul 10, 2025 S-1/A Jul 1, 2025 CORRESP Apr 9, 2025 CORRESP Apr 8, 2025